• Users Online: 608
  • Print this page
  • Email this page


 
 Table of Contents  
LETTER TO THE EDITOR
Year : 2019  |  Volume : 31  |  Issue : 4  |  Page : 295

Reply from authors for Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes


1 Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
2 Department of Nursing, Tzu Chi University of Science and Technology, Hualien, Taiwan
3 Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
4 Department of Metabolism and Endocrinology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; School of Medicine, Tzu Chi University, Hualien, Taiwan
5 Institute of Medical Sciences, Tzu Chi University; School of Medicine, Tzu Chi University; Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan

Date of Web Publication16-Sep-2019

Correspondence Address:
Dr. Bang-Gee Hsu
Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 707, Section 3, Chung-Yang Road, Hualien
Taiwan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tcmj.tcmj_188_19

Rights and Permissions

How to cite this article:
Lu CW, Lee CJ, Hou JS, Wu DA, Hsu BG. Reply from authors for Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes. Tzu Chi Med J 2019;31:295

How to cite this URL:
Lu CW, Lee CJ, Hou JS, Wu DA, Hsu BG. Reply from authors for Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes. Tzu Chi Med J [serial online] 2019 [cited 2019 Oct 17];31:295. Available from: http://www.tcmjmed.com/text.asp?2019/31/4/295/266926

Dear Editor,

We thankYasriand Wiwanitkit for their comments on our work [1]. In their response, they showed other factors that might alter the serum leptin level and this might be a limitation in using serum leptin as a clinical parameter in metabolic syndrome such in liver disease [1]. Many factors may affect serum leptin levels such as physical activity, statin used and pharmacological intervention toward against renin-angiotensin system [2]. In our study did not show significantly different of leptin levels between those treated or not with statins, fibrates, or antidiabetic drugs on peripheral arterial stiffness in patients with type 2 diabetes mellitus [3]. Leptin is known to contribute to fibrogenesis in chronic liver diseases [4]. However, studies on leptin levels and liver disease are controversial [4]. Further studies are needed to confirm the liver disease on serum leptin levels in the future.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Yasri S, Wiwanitkit V. Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes. Tzu Chi Med J 2019;31:294.  Back to cited text no. 1
  [Full text]  
2.
Tsai JP. The association of serum leptin levels with metabolic diseases. Tzu Chi Med J 2017;29:192-6.  Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Lu CW, Lee CJ, Hou JS, Wu DA, Hsu BG. Positive correlation of serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes. Tzu Chi Med J 2018;30:10-4.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in liver cirrhosis. Int J Mol Sci 2017;18:E1392.  Back to cited text no. 4
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed65    
    Printed2    
    Emailed0    
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]